SEC Form 4/A · accession 0001209191-17-013934
Adamas Pharmaceuticals Inc · ADMS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Gregory T Went
Officer — Chief Executive Officer · Director
Period of report
Jun 15, 2016
Accepted (ET)
Feb 23, 2017 · 5:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001328143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2016 | M | 204,900 | $1.875 | A | 263,658 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This amendment is being filed solely to add the written authorization attached hereto.